Navigation Links
Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
Date:2/28/2008

-Spectral joins leading Japanese medical centres in presenting data on

clinical utility of EAA(TM) diagnostic-

TORONTO, Feb. 28 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced that it will present new findings demonstrating the clinical utility of its EAA(TM) Endotoxin Activity Assay, the only FDA cleared diagnostic for the measurement of endotoxin, at the 12th Annual Critical Care for Endotoxemia congress. The conference takes place in Fukuoka, Japan from February 28th-29th, 2008 and focuses on the role of endotoxemia in sepsis in critically ill patients. The Company and a number of leading medical centres in Japan including the Tokyo Medical Clinic, Osaka City General Hospital and Iwate Medical University will each present findings using data collected with Spectral's EAA(TM) product that highlight the clinical utility of the diagnostic.

"More than one-third of the presentations being given at this important conference use data collected with our EAA(TM) and highlight the value of our product. With Japan being one of the leading nations that emphasize the importance of endotoxin and its role in sepsis, our unique EAA(TM) diagnostic plays a prominent role in patient care," said Dr. Paul Walker, President and CEO of Spectral Diagnostics. "This data supports our expanded distribution relationship with Toray, which commenced last quarter. Toray's therapeutic column, Toraymyxin, is highly effective in removing endotoxin from the bloodstream and together with EAA(TM) has been recognized in Japan as a valuable combination for the diagnosis, treatment and monitoring of patients with endotoxemia."

Debra Foster, Director of Spectral's Sepsis Program, will present Friday February 29th at 8:30am Japanese Standard Time. Following the conference, the findings presented will be published in the Japan Journal for Critical Care for Endotoxemia.

About Spectral Diagnostics

Spectral is a develo
'/>"/>

SOURCE Spectral Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. US Patent and Trademark Office Allows CRis Patent Application for Spectral Imaging of Deep Tissue
3. CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 This ... of pharmaceutical advertising and promotion, and review the ... will learn how to apply these principles through ... ,     The fundamentals on FDA regulations ... promotional labeling ,     Assessing traditional and newer ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics [Diabetes & Oncology] ... to their offering.      (Logo: ...
(Date:6/18/2013)... June 18, 2013 As a ... Inc proudly announces the release of their infographic ... Fitness ". , MeMD's goal was to leverage ... of Health 2.0, Health 3.0 and mHealth.The infographic ... transform medical care and the fitness industry in ...
Breaking Biology Technology:Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... NEW YORK, June 5 Crystal Research Associates, ... Informational Overview(R),(EIO(R)) on Arana Therapeutics Ltd. (AAH: ASX). ... http://www.crystalra.com ., Arana Therapeutics Ltd. ("Arana" ... antibody therapeutics to treat,inflammatory diseases and cancer. Arana,s ...
... American Oriental,Bioengineering (NYSE: AOB ) announced today ... The decision to cancel its,convertible preferred stock offering ... conditions resulting in terms that were not acceptable ... Statements made in this press release are forward-looking ...
... Calif., June 5 Exelixis,Inc. (Nasdaq: EXEL ) ... with Deerfield Management, a leading healthcare investment,organization and significant ... in financing through a flexible credit facility. The,funds can ... months at Exelixis,discretion. Exelixis is under no obligation to ...
Cached Biology Technology:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 3Exelixis Receives $150 Million Funding Commitment From Deerfield Management 2Exelixis Receives $150 Million Funding Commitment From Deerfield Management 3Exelixis Receives $150 Million Funding Commitment From Deerfield Management 4Exelixis Receives $150 Million Funding Commitment From Deerfield Management 5
(Date:6/17/2013)... State University research associate has received a prestigious fellowship ... prevent the spread of malaria. , Bart Bryant, research ... Health,s National Research Service Award Individual Postdoctoral Fellowship, which ... Kansas State University researcher to receive the award and ... such an award. , Bryant, a university doctoral graduate ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
(Date:6/15/2013)... -- A drug approved in Europe to treat osteoporosis ... breast cancer cells, even in cancers that have become ... Cancer Institute study. , The findings, presented June 15, ... Francisco, indicate that the drug bazedoxifene packs a powerful ... breast cancer cell growth, but also flags the estrogen ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... federal government will spend $21 billion for HIV/AIDS research, ... paying off? A study published in the July 1 ... online, indicates that it is--and more so than previously ... MPH, Kenneth Freedberg , MD, MSc and colleagues at ...
... and ferrets against a highly lethal avian influenza virus, ... St. Jude Children's Research Hospital. The vaccine was developed ... finding, coupled with results of previous studies that showed ... a vaccine would protect humans against multiple variants of ...
... water cycle and havens for wildlife, but they ... collaboration with the Ramsar Convention Secretariat, has been ... provide detailed wide-area views of individual wetlands to ... the success of wetland conservation ultimately comes down ...
Cached Biology News:New study calculates millions of years saved in lives of AIDS patients 2St. Jude test of bird flu vaccine proves successful 2African wetland managers armed with new technology 2
6X Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Agarose Gel Loading Dye Mixture 6X...
Biology Products: